• Home
  • COVID-19
    • Infection Control Program
    • Environment Control Program
  • About Us
    • Leadership
      • Board of Directors
      • Consultants
      • Our Team
    • Partners
  • Product
    • Infectious Diseases – dxn1
      • dxn1 BactFast
      • dxn1 FungiFast
      • dxn1 Virfast
      • dxn1 digitalABST
    • Oncology
      • gSeek Onco+
      • gSeek Bone
      • gSeek Brain
      • GSeek Exome
      • GSeek Breast
      • GSeek ColoRectal
      • gSeek Kidney
      • gSeek Lung
      • gSeek Liver
      • gSeek Leukemia
      • gSeek Pancreas
      • gSeek Prostate
      • GSeek Carrier Screening
    • Transplant
      • gSeek Transplant High Resolution
      • gSeek Transplant Low Resolution
    • Pediatrics
      • GSeek Newborn Screening
      • gSeek Rare Diseases
    • Mother & Baby Wellness
      • gScan NIPT
      • gScan NIPT+
      • gScan PGD
      • gScan PGS
  • Services
    • Clinical Diagnosis
    • Research
  • Technology
    • NGS
    • Genetic Consultation
    • Case Studies
      • Local
      • International
      • Archives
  • FAQs
  • Testimonials
  • Contact Us
Credence Genomics Credence Genomics

Credence Genomics

  • Home
  • COVID-19
    • Infection Control Program
    • Environment Control Program
  • About Us
    • Leadership
      • Board of Directors
      • Consultants
      • Our Team
    • Partners
  • Product
    • Infectious Diseases – dxn1
      • dxn1 BactFast
      • dxn1 FungiFast
      • dxn1 Virfast
      • dxn1 digitalABST
    • Oncology
      • gSeek Onco+
      • gSeek Bone
      • gSeek Brain
      • GSeek Exome
      • GSeek Breast
      • GSeek ColoRectal
      • gSeek Kidney
      • gSeek Lung
      • gSeek Liver
      • gSeek Leukemia
      • gSeek Pancreas
      • gSeek Prostate
      • GSeek Carrier Screening
    • Transplant
      • gSeek Transplant High Resolution
      • gSeek Transplant Low Resolution
    • Pediatrics
      • GSeek Newborn Screening
      • gSeek Rare Diseases
    • Mother & Baby Wellness
      • gScan NIPT
      • gScan NIPT+
      • gScan PGD
      • gScan PGS
  • Services
    • Clinical Diagnosis
    • Research
  • Technology
    • NGS
    • Genetic Consultation
    • Case Studies
      • Local
      • International
      • Archives
  • FAQs
  • Testimonials
  • Contact Us

Board of Directors

Dr. Vaz S Gnanam

Chairman / Chief Executive Officer

Dr. Vaz, though a qualified doctor of medicine, having practiced in the National Health Service, United Kingdom, has done research and study into the applications of Next Generation Sequencing in relation to clinical genomics. This integrates not only with his passion for medicine but for genomics and IT as well.

Over two years have been spent in R&D building a virtual platform composed of biotech, mathematics and computer software which represent the unique products that Credence has launched from this platform.

He also serves as the Managing Director of Providence Global (Pvt) Ltd, Director of St. Anthony’s Industries Group Ltd and Director of Orion Towers (Pvt) Ltd.

Mrs. Pradeepa A. C. Gnanam (B.Arch)

Director

Pradeepa a qualified architect plays a key role as an advisor on the board of Credence and is primarily involved in the design and structure of d36t Labs.

Her Previous experience includes working in the private sector in India. She has designed buildings for both commercial and private real estate while working for Amly Consultants in Chennai, India.

Mr. Raveen Wickramasinghe

Director

Raveen Wickramasinghe an Entrepreneur/Venture Capitalist. He serves as Co-CEO of Ruhunu Hospitals (Pvt) Ltd and Managing Director of RW Holdings (Pvt)Ltd. He is also a Co-Founder of two tech startups in Sri Lanka. As a venture capitalist, he concentrates on disruptive technologies and platforms which can be scaled globally. His passion lies in medical technology investments as he has close upon a decade of experience being part of the healthcare industry.

He has obtained an MA (Hons) in Accounting and Finance from the University of Edinburgh and an MSc in Entrepreneurship and Innovation from Emlyon Business School.

Mr. Janith K. Liyanage

Director

Janith K. Liyanage is a Board Director of Ruhunu Hospital (Pvt) Ltd and an Entrepreneur. He is part of the second generation of Ruhunu Hospitals owners and currently serves as a Co-CEO playing a significant role in restructuring the company through his management expertise. He has also played a pivotal role in strategy and business development of the organization.

He has obtained a BSc in Physical Science from the University of Colombo.

Hotline

+94 705551990

011 2890687 / 011 2818370

info@credencegenomics.com

12-3/2 Sunethra Devi Road,
Kohuwala, Sri Lanka.

Call me back

Please fill out this form if you would want us to call you back.

captcha

Latest News Feed

https://www.credencegenomics.com/news/apollo-india-launches-dna-based-diagnostics-with-sri-lankas-credence-genomics/

Apollo India launches DNA based diagnostics with Sri Lanka’s Credence Genomics

December 3, 2017

Chennai – The Apollo Hospitals Group, India’s largest integrated... Read More

https://www.credencegenomics.com/news/eye-live-interview-dr-vaz-santosh-gnanam-ceo-director-credence-genomics/

EYE LIVE INTERVIEW DR. VAZ SANTOSH GNANAM – CEO / DIRECTOR – CREDENCE GENOMICS

December 2, 2017

Eye Live morning TV show interviewing Dr. Vaz Santosh... Read More

https://www.credencegenomics.com/news/bmc-infectious-diseases-publishes-credence-rid-bactfast-fungifast/

BMC Infectious Diseases publishes Credence RID, Bactfast & Fungifast

December 2, 2017

Credence Genomics Ltd., Sri Lanka’s premier specialised DNA diagnostics... Read More

View All

© Credence Genomics 2023. BenWorldwide | Feedback

Thank you

Your inquiry has been received.

Close